eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community


All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

A study for a 35-year old woman who takes Ribavirin, Pegasys, Neupogen

Summary: 8 female patients aged 35 (±5) who take the same drugs are studied.

This is a personalized study for a 35 year old female patient who has Hepatitis C. The study is created by eHealthMe based on reports from FDA and social media.

 

On Mar, 30, 2015: 8 females aged 30 (±5) who take Ribavirin, Pegasys, Neupogen are studied

Ribavirin, Pegasys, Neupogen outcomes

Information of the patient in this study:

Age: 30

Gender: female

Conditions: Hepatitis C

Drugs taking:
- Ribavirin (ribavirin): used for 1 - 6 months
- Pegasys (peginterferon alfa 2a): used for 1 - 6 months
- Neupogen (filgrastim): used for 1 - 6 months

Drug interactions have: most severe fatigue, severe bone and joint pain, moderate liver problems, severe brain mass, severe anxiety

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

InteractionNumber of reports on eHealthMe
Fatigue4 (50.00% of females aged 30 (±5) who take the drugs)
Bone And Joint Pain2 (25.00% of females aged 30 (±5) who take the drugs)
Liver Problems2 (25.00% of females aged 30 (±5) who take the drugs)
Brain Mass2 (25.00% of females aged 30 (±5) who take the drugs)
Anxiety2 (25.00% of females aged 30 (±5) who take the drugs)

(as an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea)

Symptom (click a symptom for in-depth analysis)Number of reports on eHealthMe
Fatigue in Hepatitis C77 (11.49% of females aged 30 (±5) who have Hepatitis c)
Bone And Joint Pain in Hepatitis C16 (2.39% of females aged 30 (±5) who have Hepatitis c)
Liver Problems in Hepatitis C1 (0.15% of females aged 30 (±5) who have Hepatitis c)
Brain Mass in Hepatitis C1 (0.15% of females aged 30 (±5) who have Hepatitis c)
Anxiety in Hepatitis C39 (5.82% of females aged 30 (±5) who have Hepatitis c)

(as an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea)

Side effect (click a side effect for in-depth analysis)Number of reports on eHealthMe
Fatigue in Ribavirin47 (9.33% of females aged 30 (±5) who take Ribavirin)
Fatigue in Pegasys48 (11.82% of females aged 30 (±5) who take Pegasys)
Fatigue in Neupogen12 (3.45% of females aged 30 (±5) who take Neupogen)
Bone And Joint Pain in Ribavirin18 (3.57% of females aged 30 (±5) who take Ribavirin)
Bone And Joint Pain in Pegasys9 (2.22% of females aged 30 (±5) who take Pegasys)
Bone And Joint Pain in Neupogen13 (3.74% of females aged 30 (±5) who take Neupogen)
Liver Problems in Ribavirin1 (0.20% of females aged 30 (±5) who take Ribavirin)
Liver Problems in Pegasys1 (0.25% of females aged 30 (±5) who take Pegasys)
Liver Problems in Neupogen1 (0.29% of females aged 30 (±5) who take Neupogen)
Brain Mass in Ribavirin1 (0.20% of females aged 30 (±5) who take Ribavirin)
Brain Mass in Pegasys1 (0.25% of females aged 30 (±5) who take Pegasys)
Brain Mass in Neupogen1 (0.29% of females aged 30 (±5) who take Neupogen)
Anxiety in Ribavirin24 (4.76% of females aged 30 (±5) who take Ribavirin)
Anxiety in Pegasys16 (3.94% of females aged 30 (±5) who take Pegasys)
Anxiety in Neupogen4 (1.15% of females aged 30 (±5) who take Neupogen)

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Ribavirin is effectiven/a100.00%
(1 of 1 people)
n/an/an/an/an/an/a
Pegasys is effectiven/a100.00%
(1 of 1 people)
n/an/an/an/an/an/a
Neupogen is effectiven/a100.00%
(1 of 1 people)
n/an/an/an/an/an/a

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
n/aNeutropenian/an/an/an/an/aPain
Sinus TachycardiaDepression
SarcoidosisFatigue
LymphadenopathyAnaemia
LeukopeniaNeutropenia
PyrexiaHeadache
FatigueChest Pain
AlopeciaDyspnoea
DepressionLip Swelling
PainPalpitations

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

 

 

 

You are not alone! Join a related support group:
- support group for people who take Ribavirin and have Fatigue
- support group for people who take Pegasys and have Fatigue
- support group for people who take Neupogen and have Fatigue
- support group for people who take Ribavirin and have Bone And Joint Pain
- support group for people who take Pegasys and have Bone And Joint Pain
- support group for people who take Neupogen and have Bone And Joint Pain
- support group for people who take Ribavirin and have Brain Mass
- support group for people who take Pegasys and have Brain Mass
- support group for people who take Neupogen and have Brain Mass
- support group for people who take Ribavirin and have Anxiety
- support group for people who take Pegasys and have Anxiety
- support group for people who take Neupogen and have Anxiety
- support group for people who have Fatigue and Hepatitis C
- support group for people who have Bone And Joint Pain and Hepatitis C
- support group for people who have Brain Mass and Hepatitis C
- support group for people who have Anxiety and Hepatitis C
- support group for people who have Hepatitis C
- support group for people who have Anxiety
- support group for people who have Bone And Joint Pain
- support group for people who have Brain Mass
- support group for people who have Fatigue
- support group for people who take Neupogen
- support group for people who take Pegasys
- support group for people who take Ribavirin

Recent related drug studies (Check your drugs):

Related drug interaction studies:

Drug effectiveness in real world:

In-depth study of side effects (who have it, when it happens and how):

In-depth study of symptoms:

Complete drug side effects:

Alternative drugs:

Drugs associated with:

Conditions associated with:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.